Robert J. Hill Photo
Email
{{vCardForm.Header}}
{{vCardForm.Body}}
{{vCardForm.CaptchaError}}
{{vCardForm.DisplayMessage}}

Bob handles corporate transactions and provides regulatory counseling relating to health care services, pharmaceuticals, and medical devices. He also assists in health care-related litigation, investigations, and disputes, and in legislative and regulatory policy issues and related advocacy and drafting.

A core element of Bob’s practice is negotiation of agreements relating to the pricing and provision of prescription drugs and other health care services. These include:

  • Rebate agreements between pharmaceutical manufacturers and pharmacy benefit managers (PBMs), managed care organizations (MCOs), or other payers, including agreements relating to formulary rebates, market share rebates, outcomes-based rebates (a/k/a value-based rebates), rebates on drugs covered under a medical benefit, and Medicaid supplemental rebates;

Credenciales

  • University of Michigan Law School, 1987, J.D., cum laude
  • University of Michigan, 1984, B.A., Economics, with High Distinction and Highest Honors

  • Distrito de Columbia

 

Premios y reconocimientos

  • Named a Life Sciences Star for Regulatory in the LMG Life Sciences Guide (2016-2021) and a Life Sciences Star for Healthcare Pricing & Reimbursement in the LMG Life Sciences Guide (2022-2024)
  • Recognized by Nightingales Healthcare News as one of Americas Outstanding Healthcare Transaction Lawyers (2008)

Notable Quotes

  • 11 May 2018 Trump Vows Cheaper Drugs Very Soon, But That’s Unlikely Law360